Breast cancer. Clinical practice guidelines in oncology.
Carlson
Robert W
RW
Allred
D Craig
DC
Anderson
Benjamin O
BO
Burstein
Harold J
HJ
Carter
W Bradford
WB
Edge
Stephen B
SB
Erban
John K
JK
Farrar
William B
WB
Goldstein
Lori J
LJ
Gradishar
William J
WJ
Hayes
Daniel F
DF
Hudis
Clifford A
CA
Jahanzeb
Mohammad
M
Kiel
Krystyna
K
Ljung
Britt-Marie
BM
Marcom
P Kelly
PK
Mayer
Ingrid A
IA
McCormick
Beryl
B
Nabell
Lisle M
LM
Pierce
Lori J
LJ
Reed
Elizabeth C
EC
Smith
Mary Lou
ML
Somlo
George
G
Theriault
Richard L
RL
Topham
Neal S
NS
Ward
John H
JH
Winer
Eric P
EP
Wolff
Antonio C
AC
D000465:Algorithms; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001940:Breast / Q000528:radiation effects; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008408:Mastectomy; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D009367:Neoplasm Staging; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000378:metabolism; D017698:Postmenopause; D017697:Premenopause; D016032:Randomized Controlled Trials as Topic; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D021701:Sentinel Lymph Node Biopsy; D013629:Tamoxifen / Q000627:therapeutic use; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D047072:Aromatase Inhibitors; D018719:Erb-b2 Receptor Tyrosine Kinases; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D000068878:Trastuzumab